March 3 Quick Takes: Resilience acquires two manufacturing facilities in North America; plus Agilent-Resolution, AbbVie-Mitokinin, Fusion-Ipsen, LianBio-ReViral and Lava
National Resilience Inc. acquired two North American biopharma manufacturing facilities: a 310,000-square-foot biologics and advanced therapeutics Boston plant from Sanofi (Euronext:SAN; NASDAQ:SNY) and a 136,000-square-foot plant for upstream, downstream and aseptic fill finish in Ontario, Canada. Founded by Bob Nelsen and Arch Venture Partners, the manufacturing company launched in 2020 with over $800 million from two financings.
Agilent buys liquid biopsy play Resolution Bioscience
Agilent Technologies Inc. (NYSE:A) said it will acquire next-generation sequencing (NGS) cancer liquid biopsy company Resolution Bioscience for $550 million upfront and up to $145 million in milestones. Resolution had about $35 million in revenue in 2020 and is expected to generate $50-$55 million in revenue in 2021...